Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Ira Mellman wants Parker Institute to restore cancer immunotherapy

While the whole world was applauding Revolution Medicines' new cancer drug, all Ira Mellman felt was disappointment and frustration. The pill, daraxonrasib, kept patients with advanced pancreatic cancer alive roughly twice as ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 12 November →